Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Plasma cell leukemia].

F Egli, K Rhyner

    Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
    |January 17, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Plasma cell leukemia, a rare condition related to multiple myeloma, affects younger patients and presents with enlarged organs. Despite intensive chemotherapy, survival remains poor, with a median of only five months.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reducing the cost of capital to finance the energy transition in developing countries.

    Nature energy·2024
    Same author

    Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.

    British journal of cancer·2006
    Same author

    Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.

    Klinische Monatsblatter fur Augenheilkunde·2005
    Same author

    Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same author

    Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck.

    Onkologie·2004
    Same author

    Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.

    European journal of cancer (Oxford, England : 1990)·2002
    Same journal

    [In Process Citation]

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1999
    Same journal

    [A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
    Same journal

    [A case from practice (305). Recurrent erysipelas--tinea pedis et unginum--chronic venous insufficiency].

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
    Same journal

    [Neuroendocrine tumors of the stomach (stomach carcinoid)].

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
    Same journal

    [Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
    Same journal

    [Mental suffering IN patients with parkinsonism].

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
    See all related articles

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Plasma cell leukemia (PCL) is an extremely rare hematologic malignancy.
    • PCL can arise secondary to multiple myeloma or as a primary 'de novo' disease.

    Observation:

    • This study details five PCL cases treated at a Medical University Polyclinic over two years.
    • Patients with PCL were generally younger than multiple myeloma patients.
    • A higher incidence of organomegaly was observed in PCL patients.

    Findings:

    • Despite receiving intensive chemotherapy comparable to multiple myeloma treatment, PCL patients exhibited a significantly worse prognosis.
    • The median survival time for patients with plasma cell leukemia was only five months.

    Implications:

    Related Experiment Videos

  • The findings highlight the aggressive nature of plasma cell leukemia.
  • There is a critical need for novel therapeutic strategies to improve outcomes for PCL patients.
  • Further research into the unique biology of PCL is warranted to develop targeted treatments.